Comparative Biosciences - Crunchbase Company Profile & Funding

Overview

Comparative Biosciences

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Comparative Biosciences

CB Rank

720836

Comparative Biosciences is a biotechnology company that provides expert scientific resources to all sectors of the biomedical community.

Acquired by

Genesis Drug Discovery & Development

Founded

obfuscation

Private

Sunnyvale, California, United States

11-50

www.compbio.com

Biotechnology

Details

Sub-Organization of

Genesis Drug Discovery & Development

Operating Status

Active

Company Type

For Profit

About the Company

Comparative Biosciences is a biotechnology company that provides pharmacology projects for IND-enabling research studies.

Phone Number

(408) 738-9260

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Preclinical Arthritis Models

Validated animal models for studying various types of arthritis to assess disease progression and therapeutic effects.

Cardiovascular Efficacy and Models

Animal models for cardiovascular and pulmonary diseases to evaluate drug efficacy and device performance.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

Comparative Biosciences

was acquired by

Genesis Drug Discovery & Development

obfuscation

Transaction Name

Comparative Biosciences acquired by Genesis Drug Discovery & Development

Acquired by

Genesis Drug Discovery & Development

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Contacts

News

Technology

View Tech Report

Monthly Web Visits

247

20.49%

in past month

IT Spend

$581.2K

This year,

Comparative Biosciences

is projected to spend

$581.2K

on IT, according to Aberdeen.

Interest Signals

Topic	Surge Score
Proposal / Quote Generation	88
PC Gamer	85
4G Backup	82

Active Website Tech Count

Comparative Biosciences

is actively using

technologies for its website, according to BuiltWith. These include

Common Crawl

Google Maps

, and

CommonCrawl Top 10m

Lists Featuring This Company

Silicon Valley Companies that Exited

5,084 Number of Organizations • $877.2B Total Funding Amount • 19,171 Number of Investors

California Acquired Companies With Fewer Than 1000 Employees

7,703 Number of Organizations • $355.6B Total Funding Amount • 20,446 Number of Investors

Silicon Valley Companies With Fewer Than 100 Employees (Top 10K)

9,937 Number of Organizations • $113.3B Total Funding Amount • 23,704 Number of Investors

Biotechnology Acquired Companies With Fewer Than 100 Employees

1,659 Number of Organizations • $52.5B Total Funding Amount • 4,215 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

Comparative Biosciences

's headquarters?

Comparative Biosciences

is located in

Sunnyvale, California, United States

Who are

Comparative Biosciences

's competitors? Alternatives and possible competitors to

Comparative Biosciences

may include

The Jackson Laboratory

WuXi AppTec

, and

Charles River Laboratories International